Contact:
4008465777
-
About Us
News & Events
-
11-29
Breakthrough in GLP-1 Global Expansion | Tonghua Dongbao's Liraglutide Injection Approved for Marketing in Peru
Recently, a liraglutide injection, developed by Tonghua Dongbao Pharmaceutical Co., Ltd. ("Tonghua Dongbao" or "the Company") and its partner, Kexing Biopharm Co., Ltd. ("Kexing Biopharm"), has been a...
-
11-26
Global Expansion | Tonghua Dongbao's Liraglutide Injection Passes the On-Site GMP Audit by ANVISA
Recently, a liraglutide injection, developed by Tonghua Dongbao Pharmaceutical Co., Ltd. ("Tonghua Dongbao" or the "Company") and its partner, Kexing Biopharm Co., Ltd. ("Kexing Biopharm"), has passed...
-
11-14
Global Expansion | Tonghua Dongbao's Insulin Aspart Injection Approved for Marketing in the Dominican Republic
Tonghua Dongbao Pharmaceutical Co., Ltd. ("the Company") recently received marketing approval for its Insulin Aspart Injection from the Ministry of Public Health and Social Welfare of the Dominican Re...
-
10-25
Global Expansion | Tonghua Dongbao's Insulin Aspart Injection Approved for Marketing in Indonesia
Tonghua Dongbao Pharmaceutical Co., Ltd. (the "Company" or "Tonghua Dongbao") recently received a drug registration certificate for its insulin aspart injection, issued by the Indonesian Food and Drug...
-
10-11
Global Expansion | Tonghua Dongbao's Insulin Glargine Injection Approved for Marketing in Myanmar
Tonghua Dongbao Pharmaceutical Co., Ltd. ("the Company") recently received marketing approval for its Insulin Glargine Injection from the regulatory authorities of Myanmar. This approval marks the Com...
-
07-02
Partnership | Tonghua Dongbao and Tofflon Enter into a Strategic Partnership to Drive Progress in Diabetes Treatment
Recently, Chairperson Li Jiahong and President Leng Chunsheng of Tonghua Dongbao Pharmaceutical Co., Ltd. ("Tonghua Dongbao" or the "Company") led a team to visit Tofflon Science and Technology Group ...